The serotonin pathway can be affected in this group of patients as the expression of monoamine oxidase-A, one of the enzymes catalyzing monoamines like serotonin, has been shown to be increased in NASH (33). Here, MAOA is linked to metabolic dysfunction-associated steatohepatitis.